603 related articles for article (PubMed ID: 26519903)
1. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signaling in Alzheimer's disease.
Erb L; Woods LT; Khalafalla MG; Weisman GA
Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
4. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
5. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
[TBL] [Abstract][Full Text] [Related]
6. Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
Mendiola-Precoma J; Padilla K; Rodríguez-Cruz A; Berumen LC; Miledi R; García-Alcocer G
J Alzheimers Dis; 2017; 55(3):1273-1283. PubMed ID: 27792010
[TBL] [Abstract][Full Text] [Related]
7. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Fumagalli M; Lecca D; Abbracchio MP
Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
[TBL] [Abstract][Full Text] [Related]
8. Role of purinergic receptors in the Alzheimer's disease.
Cieślak M; Wojtczak A
Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease.
Moore D; Iritani S; Chambers J; Emson P
Neuroreport; 2000 Nov; 11(17):3799-803. PubMed ID: 11117494
[TBL] [Abstract][Full Text] [Related]
10. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
11. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
13. The P2X7 receptor: a new therapeutic target in Alzheimer's disease.
Illes P; Rubini P; Huang L; Tang Y
Expert Opin Ther Targets; 2019 Mar; 23(3):165-176. PubMed ID: 30691318
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus.
McLarnon JG; Ryu JK; Walker DG; Choi HB
J Neuropathol Exp Neurol; 2006 Nov; 65(11):1090-7. PubMed ID: 17086106
[TBL] [Abstract][Full Text] [Related]
15. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
[TBL] [Abstract][Full Text] [Related]
16. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological Role and Medicinal Chemistry of A
Merighi S; Borea PA; Varani K; Vincenzi F; Travagli A; Nigro M; Pasquini S; Suresh RR; Kim SW; Volkow ND; Jacobson KA; Gessi S
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566035
[TBL] [Abstract][Full Text] [Related]
18. Purinergic receptors in embryonic and adult neurogenesis.
Oliveira Á; Illes P; Ulrich H
Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
[TBL] [Abstract][Full Text] [Related]
19. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
